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Chronic exposure of hairless mice to ultraviolet B (UVB) 
radiation is associated with inflammation as well as an altered 
macromolecular composition of the dermis. This study was 
designed to determine whether or not various systemic anti-
inflammatory agents inhibit chronic UVB-induced changes 
in the macromolecular content of the dermis and, if so, 
whether each agent had the same or different effects. The 
agents and doses were chosen for their ability to inhibit the 
changes induced by a single exposure to UVB radiation (in-
creased vasopermeability, neutrophil accumulation, and 
skin-fold thickness). Indomethacin, a cyclooxygenase inhibi-
tor, and meclizine, an H1 histamine receptor antagonist, were 
administered from slow-release pellets. BW755C, a com-
bined cyclooxygenase and lipoxygenase inhibitor, was ad-
ministered intraperitoneally 30 min prior to UVB exposure. 
A ge-related changes in skin result from two distinct but concurrent processes. Intrinsic aging is assumed to re-sult from a genetically programmed sequence of events, whereas extrinsic aging is dominated by pho-toaging, which is the response to cumulative il~ury 
induced by years of exposure to ultraviolet radiation (UVR) from 
the sun. The changes induced by chronic UVR exposure of human 
and hairless mouse dermis are similar. Histologically, photoaged 
dermis shows marked increases in glycosaminoglycans (GAGs) and 
elastic tissue, degeneration of the elastin into an amorphous mass, 
decreased staining of collagen, increased numbers of dermal fibro-
blasts and mast cells, and appearance of inflammatory infiltrate [I-
S]. Biochemically, the amount of collagen appears to increase or 
decrease depending on the amount of exposure to UV radiation 
[6,7]. Elastin, measured as desmosine, is markedly increased in pho-
toaged human and mouse skin [7 ,8]. The total uronic acid content of 
photoaged mouse skin and human skin increases greatly compared 
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Animals were exposed to UVB three times per week for 
20 - 26 weeks or were unirradiated. The elastin, glycosarni-
no glycan and collagen content of the skin were determined 
by measuring the desmosine, uronic acid, and hydroxypro-
line levels, respectively. The amount of each macromolecule 
per area of skin increased after chronic UVB exposure. The 
increase in desmosine was inhibited by indomethacin; the 
increase in hydroxyproline was inhibited by meclizine and 
BW75SC. None of the agents inhibited the uronic acid in-
crease. These results suggest that chronic inflammation con-
tributes to the dermal changes seen in chronically UVB-ex-
posed skin and that different inflammatory mediators are 
involved in the increases observed in elastin, glycosarninogly-
cans, and collagen.] Invest DermatoI100:186-193, 1993 
to age-matched control skin [7,9]. Action spectrum studies in hair-
less mice indicate that ultraviolet B (UVB) radiation (290 - 320 nm) 
more efficiently produces these changes than longer-wavelength 
optical radiation [10]. 
These changes in photoaged skin have been attributed to the 
inflammation induced by each exposure to UVR. Several observa-
tions are consistent with this hypothesis including the presence of 
inflammatory cells in photoaged skin [1,2,4] and the inhibition of 
chronic UVB-induced changes in the histology of hairless mouse 
skin by topical application of the anti-inflammatory agents hydro-
cortisone and naproxen [11]. 
This study was designed to determine whether systemic anti-in-
flammatory agents are able to inhibit changes induced by chronic 
UVB exposure of hairless mouse skin by measuring several dermal 
macromolecules. In addition, anti-inflammatory agents were se-
lected that inhibit different inflammatory pathways to determine 
whether selective inhibition of the UVB-induced changes in macro-
molecular content could be detected. 
MATERIALS AND METHODS 
Animals Female, hairless albino mice (Skh-hairless-l), 6-7 
weeks old, were obtained from Charles River Laboratores. Mice 
were identified by ear notches and housed in groups of five. 
Chemicals Meclizine and indomethacin pellets were obtained 
from Inovative Research (Toledo, OH). BW755C was a gift of the 
Burroughs Wellcome Co. (Beckenham, UK) . Evans blue and hexa-
decyltrimethylammonium bromide were obtained from Sigma (St. 
Louis, MO). Desmosine, antidesmosine antiserum, and Bolton 
Hunter-labeled desmosine were obtained from Elastin Products 
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Table I. Fluences of UVB Radiation (mJ/cm2) Administered at Each Exposure for Chronic Exposure Studies 
Experiment 2 3 4 5 6 7 8 
1 (5 .1 J/cm2, 12.5 25 37.5 50 -+ 60 
26 weeks) 
2 (4.8 J/cm2, 12.5 25 40 60 80 -+ 
22 weeks) 
3 and 4 (6.8 J/cm2, 30 40 55 75 -+ 100 
20 weeks) 
Co. (Owensville, MO). Goat anti-rabbit antiserum was from Or-
ganon Teknika Corp. (West Chester, PA). Chloramine T, 30% 
H 2 0 2 , Bis-Tris buffer, and 4-hydroxyproline were from Sigma (St. 
Louis, MO). o-dianisidine dihydrochloride was obtained from East-
man Kodak (Rochester, NY) and 4-(dimethylamirto)-benzaldehyde 
w as from Aldrich (Milwaukee, WI) . Soluene 350 was from Packard 
Instrument Co. (Downers Grove, IL). Perchloric acid was from J.T. 
Baker, Inc. (Phillipsburg, NJ). 
AdlDinistration of Agents Pellets were implanted through an 
incision just anterior to the scapulae and were placed to rest over the 
skull. Pellets were implanted every 3 weeks at least 2 d prior to an 
irradiation. BW755C was administered as an intraperitoneal (ip) 
injection in 1 : 5 ethanol: saline 30 min prior to irradiation. 
Irradiation Mice were irradiated in separate chambers (3 cm X 
1.25 em plexiglass stalls covered with a wire mesh) to ensure uni-
fo rm radiation of the dorsal surface and placed under a bank of 12 
UVB-Ho-90° bulbs (Elder Pharmaceuticals Inc.). The height of the 
UVB bulbs was adjusted to provide 0.5 mW /cm2 at the dorsal 
surface of the mice as measured with an IL-1700 radiometer 
equipped with a SED 240 UVB detector (International Light Inc., 
Newburyport, MA) prior to each irradiation. The spectrum of the 
bulbs was measured periodically with a spectroradiometer (Model 
742 Optronix Laboratories Inc., Orlando, FL). The spectral output 
was 76.8% between 290 and 320 nm, 19.7% between 320 and 
400 nm, and 3.5% between 200 and 290 nm. Mice were irradiated 
on Monday, Wednesday, and Friday for periods between 20 and 26 
w eeks. Three schedules were followed as shown in Table I. Each 
group contained ten mice. 
Assays for Acute UVB-Induced Changes Measurements were 
made of skin-fold thickness, vascular permeability, and neutrophil 
accumulation 24 h after a single exposure to UVB radiation. 
Briefly, the skin along an imaginary line from axilla to hip was 
pulled up, and its thickness measured with a spring-loaded microme-
ter (Fowler, Biggsfield, UK). Vascular permeability was quantita-
tively assayed by the leakage from vessels of an albumin-bound 
anionic dye, Evans Blue. Evans Blue (1 %, lOfJ.ljg body weight) was 
injected via the tail vein; 4 h later the animals were killed and the 
dorsal skin removed and biopsied. Biopsies were solubilized and the 
optical absorbance of Evans Blue was measured at 620 nm. Neutro-
phils accumulating in skin were quantified by measuring myeloper-
oxidase activity in homogenized biopsies with the method of Brad-
ley et al. [12] . 
Preparation of Skin Samples After the mice were killed by 
ether inhalation, the skins were removed and spread on a sheet of 
dental wax. All measurements were made on non - tumor-bearing 
areas of skin. Two punches (3 mm) were taken for light microscopy 
and frozen sections. For the desmosine and the hydroxyproline 
assays, a single 4-mm or two 2-mm biopsy punches were taken, 
weighed, and hydrolyzed (6 N HCl) at 110°C for 24 h. The hydrol-
ysate was evaporated to dryness at 55 °C under a stream ofN2 , then 
dried under vacuum overnight. For uronic acid measurements in 
experiments 1 and 2, the remainder of the skin was weighed and 
digested overnight at 60 °C in a papain solution (1 mg/ml papain, 
5 mM cysteine,S mM EDTA in sodium acetate buffer, pH 6.0) . 
Samples were centrifuged and the fatty layer was removed and dis-
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carded. The aqueous layer was analyzed for uronic acid content. For 
experiments 3 and 4, three 6-mm punch biopsies were taken and 
diges~ed in 1 ml of the same mixture overnight. The following 
mornmg, an additional 0.5 ml papain solution added and incubation 
continued for 4 h. The digest was then centrifuged at 500 X g and 
the supernatant was dialyzed against distilled water for 24 h with 
two changes of water. The dialyzed samples were assayed for uronic 
acid content. 
Desmosine Desmosine was measured by a modification of the 
radioimmunoassay method of Starcher [13]. In experiments 1 and 2, 
after incubation of the re-dissolved hydrolysate with probe and 
antibody solution, the bound probe was immobilized on nitrocellu-
lose filters, washed, ~nd cou.nted in a ~amma counter. For experi-
ments 3 and 4, after mcubatlOn the mIxture was further incubated 
with 100 fJ.l of goat anti-rabbit antiserum diluted 32 times at4 °C for 
2 h. Polyethyleneglycol (MW 8000, 15%, 100 fJ.l), was added and 
the mixture was centrifuged at 300 X g for 1 h. The pellets were 
counted on a LKB 1272 gamma counter. 
Uronic Acid Glycosaminoglycan content of skin was measured 
by uronic acid analysis according to the method of Bitter and Muir 
[14] . 
Hydroxyproline Hydroxyproline was assayed by a modification 
of the method of Stegemann and Stalder [15] . 
Histology Biopsy specime.ns were fixed in formaldehyde-cetyl-
pyridinium chloride: Four-micrometer s~ctions were cut from paraf-
fin blocks. The sectIOns were stamed With hematoxylin and eosin 
for evaluation of the inflammatory infiltrate, the epidermis, and the 
cellular constitutents of the dermis. Resorcin fuchsin-stained sec-
tions were utilized for evaluation of elastic fibers. Colloidal iron 
stain was used to evaluate GAG content and distribution. The thick-
ness of the epidermis was measured with an ocular micrometer. 
Mast cells were counted on resorcin fuchsin-stained sections. An 
eyepiece micrometer with a 10 X 10 square grid (0.25 mm/side) 
was used. The microm~ter was aligned with one edge along the 
dermaljepldermalJunctlOn, and all mast cells falling within the grid 
were counted. The micrometer was moved along the length of each 
section so that an average of 10 fields were counted per section. 
Three sections per group were counted. 
Neutrophils were counted on 5-fJ.m frozen sections fixed in ace-
tone, and .stained wi~h benzidine dihydrochloride (0.3% in 50% 
ethanol With 1 % sodIUm acetate, 2.1 % H20 2 , pH 6.0). Safranin ° 
was included in the £rimary stain. Slides were counterstained with 
1 % methyl green [16 J. Neutrophils were counted as described above 
for mast cells. 
Tumors Any mass with a greater than 1.5-mm diameter was ten-
tatively considered to be a tumor. Histologic identification of tumor 
type was not made. 
Statistics Two-tailed, non-paired Student t test was used to evalu-
ate differences between experimental groups. 
RESULTS 
Effects of Agents on Acute Responses of Skin to UVB To 
select the proper doses of anti-inflammatory agents to be used for 
the chronic UVB-exposure studies, the influence of indomethacin, 
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Figure 1. Summary of the effects of anti-inflammatory agents on acute 
UV -induced changes in hairless mouse skin. The values for vasopermea-
bility, number of neutrophils, and skin-fold thickne~s are normalized to 
100 for the irradiated, non-drug-treated control arumals. These control 
groups are shown as solid bars. All value~ shown are ~or irradiated animals. 
Groups treated with 0.10 mg/pellet mdomethaon are shown as dark 
shaded bars, groups treated with 1.5 mg/pellet meclizine (or 0.25 mg/pellet 
for vasoperrneability) are shown as light shaded bars, and groups treated 
with 30 mg/kg BW755C are shown as ope/l bars. The anti-inflammatory 
agents did not alter the values for non - UVB-exposed groups compared to 
the no-drug, no-UVB control groups except for indomethacin, which 
decreased the skin-fold thickness (see Results). The values shown are 
mean values ± SD values for groups of five mice. Asterisks, p < 0.01 com-
pared to the irradiated, non-drug-treated control groups. 
meclizine, and BW755C on skin responses to a single UVB expo-
sure were assessed. Three measurements were made to quantify the 
inflammation at 24 h, namely, vascular permeability, accumulation 
of neutrophils, and skin-fold thickness. Based on preliminary mea-
surements made using injections of indomethacin and meclizine, 
doses of these agents incorporated into slow-release pellets were 
selected. Experiments were performed 7 -10 d after placement of 
the pellet. BW755C was given as an ip injection 30 min prior to 
UVB exposure. Preliminary studies indicated that injection times 
between 2 hand 30 min prior to irradiation gave equivalent results. 
A series of concentrations of the three anti-inflammatory agents 
were tested. The results for concentrations of indomethacin, mecli-
zine, and BW755C that were the same as, or close to, those used in 
the chronic exposures are shown in Fig 1. These are 0.10 mg/pellet 
for indomethacin, 1.5 mg/pellet for meclizine (except for vasoper-
meability where only 0.25 mg/pellet was tested), and 30 mg/kg for 
BW755C. 
A single exposure to 75 mJ/cm2 of UVB radiation induced a 
4.6-times increase in the vascular permeability of hairless mouse 
skin over unirradiated skin as measured by the amount of Evans blue 
dye accumulated in the skin. All three agents inhibited significantly 
the UVB-induced increase in vascular permeability when compared 
to the non - drug-treated, irradiated control group. The drugs alone, 
without UVB exposure, did not alter the vasopermeability. The 
myeloperoxidase activity of hairless mouse skin increased 2.4 times 
at 24 h after a single exposure to 180 mJ/cm2 of UVB radiation. 
Indomethacin and meclizine but not BW755C decreased the en-
zyme activity in irradiated skin compared to the irradiated, no-drug 
control group. The drugs alone , without UVB exposure, did not 
alter the myeloperoxidase activity. A single exposure to 180 mJ/ 
cm2 UVB radiation induced an 0.31-mm increase in skin-fold 
thickness in the untreated control group. Indomethacin inhibited 
the UVB-induced increase in skin-fold thickness but meclizine and 
BW755C were ineffective. Imdomethacin, but not meclizine or 
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Figure 2. Histology of unirradiated and UVB-irradiated hairless mouse 
dorsal skin. a) Unirradiated, age-matched control mouse (experiment 2, 
22 weeks). Note the thin epidermis and dermis. b) UVB-irradiated, non-
drug-treated control mouse. Note the thickened epidermis and prominent 
papillary dermis (asterisk). Hematoxylin and eosin; bar, 50 j1m. 
BW755C, also decreased the skin-fold thickness of unirradiated 
animals but the change was not enough to account for the large 
decrease observed in the irradiated animals. 
Histology and Tumors After Chronic UVB Exposure Un-
irradiated, age-matched control mice as well as meclizine-, indo-
methacin-, and BW755C-treated mice that were not irradiated 
showed similar skin morphology (Fig 2). The epidermis was typi-
cally 2 - 3 cells thick. The adventitial dermis was thin. The reticular 
dermis contained scattered inflammatory cells and mast cells, pre-
dominantly located perivascularly in th e deep dermis (Fig 3). There 
were small quantities of glycosaminoglycans identified predomi-
nately in the adventitial dermis. UVB-irradiated mice including 
meclizine-, indomethacin-, and BW755C-treated mice as well as 
control mice showed similar histologic findings. The epidermis was 
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Figure 3. Staining of unirradiated and UVB-irradiated hairless mouse 
skin for elastin and mast cells. a) Unirradiated, age-matched control 
[!louse (experiment 2, 22 weeks). Note the fine fibrillary elastic tissue and 
the mast cells (arrows) in the deep dennis. b) UVB-irradiated, non-drug-
treated control mouse. Note the increased number of mast cells in the 
deep dennis. No clumps of elastic tissue are present. Resorcin fuchsin; bar, 
SOJ.lm. 
thickened to approximately 3 - 4 cell layers. The papillary dermis 
contained a thicker layer of fine fibrillar collagen. There were more 
mast cells scattered throughout the dermis, both perivascularly as 
well as in the interstitium. In addition to the mast cells, there were 
lymphocytes and scattered neutrophi ls. The quantity of GAGs was 
increased with the most marked accumulation being in the adventi-
tial dermis. The elastic fibers appeared slightly thickened and in-
creased in number. There were no clumps of elastic tissue (as may be 
seen in solar elastosis). 
Measurements of dermal thickness made on tissue sections 
showed a 53-100% increase in animals that are UVB exposed 
(Table II). This result is supported by measurements of skin-fold 
thickness showing that the dorsal skin was 50 to 100% thicker in 
irradiated, non-drug treated anima ls compared to unirradiated con-
trols. The UVB-induced thickening was only decreased by indo-
methacin (0.10 mg/pellet). 
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The average number of dermal mast cells counted in non-irra-
diated, non - drug-treated control skin from the four experiments 
was 148 cells/mm2 (Table III). Exposure to UVB radiation in-
creased the number by factors of 1.9 to 2.3 in the non-treated and 
placebo-treated groups. None of the agents significantly inhibited 
the UVB-induced increase in mast cells over the increase seen in 
unirradiated groups. UVB-exposure increased the number of neu-
trophils counted in the dermis by factors of 1.6 and 2.1 (Table II). 
Indomethacin (0.10 mg/pellet) inhibited this increase. Meclizine 
also inhibited the UVB-induced increase although the placebo pel-
let had a s'imilar effect. These results are similar to those found for 
acute UVB-induced changes, namely, indomethacin inhibited the 
neutrophil increase and the inhibition was produced by one dose of 
meclizine. 
!umo.rs were ~ounted at the end of the irradiation period for the 
aJ1lmals 111 expenments 3 and 4. In experiment 3, two tumors ap-
peared on the irradiated animals treated with indomethacin. In ex-
periment 4, only one tumor appeared on an unirradiated animal 
(placebo pellet group). The number of tumors on irradiated animals 
in experiment 4 were no drug [3J; placebo pellet [3J; meclizine, 
0.5 mg [7J; and meclizine, 1.5 mg [13J. 
Effects of Chronic UVB Exposure on Dermal Macromole-
cules in the Presence and Absence of Anti-Inflammatory 
Agents Chronic exposure of mice to UVB radiation employed 
three different exposure protocols. Mice received either 5.1 J/cm2 
in 26 weeks, 4.8 J/cm2 in 22 weeks, or 6.8 J/cm2 in 20 weeks as 
described in Materials and Methods and Table I. The skin of the 
irradiated groups was visibly red and had more scales than the un-
irradiated groups. 
Chronic exposure of hairless mouse skin to UVB radiation has 
previously been shown to alter the macromolecules in the dermis. 
The change in dermal macromolecu les will be described primarily 
using the amount of macromolecule per area of skin. The "amount 
per area" was chosen over "amount per wet weight" because the 
measurements of area were more reproducible and the wet weight is 
highly influenced by the degree of inflammation and GAG content. 
The results of measurements for elastin, GAGs, and collagen con-
tent per area and per weight are shown in Tables IV, V, and VI, 
respectively. Only the data expressed per area were statistically eval-
uated. 
The elastin content of skin was measured as the amount of the 
cross-linking amino acid derivative desmosine . In the four experi-
ments, the average amount of desmosine per area of unirradiated 
skin (4.4 ± 0.9 nmoles/cm2) approximately doubled upon chronic 
UVB exposure to 8.0 ± 2.3 nmoles/cm2 (Table IV). In individual 
experiments the increase in desmosine per skin area increased be-
tween 43% and 98%. 
Indomethacin at 0.10 mg/pellet inhibited the chronic UVB-in-
duced increase in desmosine per cm2 compared to the irradiated 
control. The indomethacin-treated (0.10 mg/pellet), unirradiated 
animals did not show a significant change in desmosine compared to 
unirradiated controls. The lower dose of indomethacin also inhib-
ited the increase in desmosine (p < 0.01) but the control, unirra-
diated group showed the same effect (p < 0.01). Meclizine (0.5 to 
1.5 mg/pellet) and BW755C did not inhibit the chronic UVB-in-
duced increase in desmosine. In fact, the desmosine level in mecli-
zine-treated (0.5 or 1.5 mg/pellet), UVB-exposed animals was 
higher than that in the groups that were only UVB exposed (p < 
0.05). 
The GAG content of skin was evaluated from the amount of 
uronic acid present. Unirradiated skin contained 41 ± 6 J,Lg/cm2 
uronic acid as determined on samples that were dialyzed before 
analysis (experiments 3 and 4, Table V). As described in Materials 
a"d Methods, the samples that were not dialyzed before uronic acid 
analysis gave lower values although these data show the same trends 
as those from samples for which the samples were dialyzed. Chronic 
UVB irradiation increased the amount of uronic acid per skin area 
by 55 to 340%. 
Indomethacin (0.05 to 0.10 mg/pellet) and BW755C did not 
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Table II. Effects of Indomethacin, Meciizine, and BW755C on the Chronic UVB-Indu ced Skin-Fold Thickness 
and Dermal Thickness in Hairless Mouse Skin 
Dermal Thickness (urn) Skin-Fold Thickness (rnrn)' 
Group NoUVB UVB NoUVB UVB 
Experiment 1 
None 93 ± 13 b 182 ± 39 0.83 ± 0.02 (9) 1.19 ± 0.07 (8) 
Indomethacin, 0.05 mg 108 ± 19 192 ± 7 0.83 ± 0.01 (5) 1.27 ± 0.10 (3) 
Experiment 2 
None 120 ± 9 183 ± 38 0.80 ± 0.06 (9) 1.21 ± 0.08 (7) 
Meclizine, 0.25 mg 108 ± 13 217 ± 38 0.77 ± 0.06 (10) 1.28 ± 0.15 (9) 
BW755C, 37.5 mg/kg 142 ± 52 229 ± 26 0.66 ± 0.06 (3) 1.17 ± 0.06 (7) 
Experiment 3 
None 141 ± 25 240 ± 46 0.77 ± 0.02 (10) 1.46 ± 0.03 (10) 
Indomethacin, 0.10 mg 154 ± 41 211 ± 36' 0.74 ± 0.02 (8) 1.53 ± 0.06 (9) 
Experiment 4 
None 142 ± 14 242 ± 35 0.77 ± 0.03 (6) 1.37 ± 0.08 (9) 
Placebo 142 ± 10 200 ± 23 0.79 ± 0.02 (10) 1.32 ± 0.06 (9) 
Meclizine, 0.5 mg 163 ± 23 264 ± 38 0.80 ± 0.02 (10) 1.29 ± 0.05 (9) 
Meclizine, 1.5 mg 179 ± 20 269 ± 45 0.78 ± 0.02 (10) 1.54 ± 0.16 (8) 
• Numbers in parentheses represent animals at the end of the experiment in that group. All groups had 10 animals initially. 
bMean±SEM. 
' p < 0.001 compared to irradiated, non-drug-treated group. 
alter the chronic UVB-induces increased in uronic acid content per 
skin area. Meclizine (0.5 or 1.5 mg/pellet) decreased the UVB-in-
duced increase in uronic acid but this difference appears to be attrib-
utable to the effect of meclizine alone, because in the unirradiated 
animals meclizine decreased the uronic acid content compared to 
untreated control groups. 
The collagen content of skin is proportional to the amount of 
hydroxyproline. The average amount of hydroxyproline in unirra-
diated mouse skin in the four experiments was 0.72 ± 0.08 mg/ 
cm2 • In each experiment, chronic exposure to UVB radiation in-
creased the amount of collagen per area of skin by 15 - 52% (Table 
VI). 
In the UVB-exposed groups, meclizine (0.5 and 1.5 mg/pellet) 
Table III. Effects of Indomethacin, Meciizine, and BW755C 
on Chronic UVB-Induced Increase in Number of Mast Cells 
and Neutrophils in Hairless Mouse Skin" 
Mast Cells per rnrn2 Neutrophils per rnrn2 
Group NoUVB UVB NoUVB UVB 
Experiment 1 
None 165 ± 21b 384 ± 21 NO' NO 
Indomethacin, 118 ± 27' 330 ± 21J NO NO 
0.05 mg 
Experiment 2 
None 139 ± 19 302 ± 66 NO NO 
Meclizine, 129 ± 10 390 ± 22 NO NO 
0.25 mg 
BW755C, 96 ± 18 304 ± 82 NO NO 
37.5 mg/kg 
Experiment 3 
None 130±1 274 ± 21 251 ± 54 390 ± 58 
Indomethacin, 184 ± 1 383 ± 6 251 ± 38 338 ± I J 
0.10 mg 
Experiment 4 
None ·157 ± 8 298 ± 21 195 ± 21 412 ± 32 
Placebo 150 ± 17 285 ± 18 218 ± 16 286 ± 24J 
Meclizine, 115 ± 8' 237 ± 14J 216 ± 42 349 ± 38J 
0.5 mg 
Meclizine, 131 ± 7' 216 ± 18J 189 ± 21 258 ± 32J 
1.5 mg 
• Number of mice in each group at end of experiment is shown in Table II. 
b Mean±SEM. 
, p < 0.001 compared to unirradiated, non-drug-treated group. 
J P < 0.001 compared to irradiated, non-drug-treated group. 
, NO, not determined. 
inhibited the UVB-induced increase in hydroxyproline per area of 
tissue. BW755C also inhibited the UVB-induced increase in hy-
droxyproline although at a lower level of significance. Indometha-
cin did not inhibit UVB-induced increase in hydroxyproline be-
cause in the unirradiated groups, indomethacin decreased the 
hydroxyproline content per skin area to the same or greater extent. 
As noted above, UVB exposure induces an increase in the wet 
weight per area of skin that is at least partially due to the increase in 
GAGs. In collagen, which is only slightly increased per unit surface 
area upon UVB exposure, the overall concentration (amount per 
weight) decreases, especially when the UVB-induced GAG increase 
is larger (experiments 3 and 4) . The concentration (amount per 
weight) of elastin in UVB-exposed skin compared to unirradiated, 
age-matched skin varied depending on the magnitude of the UVB-
induced increase in elastin per area. 
Table IV. Effects of Indomethacin, Meclizine, and BW755C 
on Chronic UVB-Induced Changes in Desmosine in Hairless 
Mouse Skin" 
Desmosine, nmoles/cm2 Desmosine, nmoles/ g 
Group NoUVB UVB NoUVB UVB 
Experiment 1 
None 4.4 ± 0.5b 6.3 ± 0.8 87 ± 15 98 ± 16 
Indomethacin, 3.4 ± 0.6 5.0 ± 0.9 86 ± 16 91 ± 21 
0.05 mg 
Experiment 2 
None 5.3 ± 0.6 10.5 ± 0.9 109 ± 11 143 ± 16 
Meclizine, 7.7 ± 0.1 9.6 ± 1.3 155 ± 21 134 ± 27 
0.25 mg 
BW755C, 4.0 ± 0.4 9.5 ± 1.4 81 ± 8 138 ± 24 
37.5 mg/kg 
Experiment 3 
None 4.7 ± 0.3 9.3 ± 0.7 110±7 120 ± 10 
Indomethacin, 4.9 ± 0.3 7.1 ± 0.8' 152 ± 11 98 ± 11 
0.10 mg 
Experiment 4 
None 3.2 ± 0.2 5.7 ± 0.3 104 ± 7 70±4 
Placebo pellet 5.1 ± 0.6 5.8 ± 0.7 127 ± 15 74±8 
Meclizine, 3.1 ± 0.2 7.6 ± 1.0 92±7 107 ± 15 
0.5 mg 
Meclizine, 4.4 ± 0.3 8.5 ± 0.6 114±8 98 ± 6 
1.5 mg 
• Number of mice in each group at end of experiment is shown in Table ll. 
bMean±SEM. 
'p < 0.005 compared to irradiated, non-drug-treated group. 
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Table V. Effects of Indomethacin, Meclizine, and BW755C 
on Chronic UVB-Induced Changes in Uronic Acid in Hairless 
Mouse Skina 
Uronie Acid, Jig/em2 Uronic Acid, Jig/g 
Group NoUVB UVB NoUVB UVB 
Experiment 1 
None 15.9 ± 0.7b 24.6 ± 1.4 297 ± 13 367 ± 21 
Indomethacin, 12.7 ± 3.5 22.3 ± 0.9 327 ± 91 388 ± 16 
0.05 mg 
Experiment 2 
None 14.0 ± 2.7 23.8 ± 3.2 295 ± 56 343 ± 46 
Meclizine, 14.7 ± 3.9 26.2 ± 1.4 309 ± 82 333 ± 18 
0.25 mg 
BW755C 13.3 ± 1.2 22.4 ± 1.7 262 ± 24 323 ± 74 
37.5 mg/kg 
Experiment 3 
None 44.8 ± 5.0 141 ± 6 920 ± 60 1430 ± 50 
Indomethacin, 38.6 ± 4.5 144 ± 9 703 ± 73 1360 ± 43 
0.10 mg 
Experiment 4 
None 36.5 ± 5.8 162 ± 15 701 ± 81 1560 ± 86 
Placebo pellet 37.4 ± 4.0 148 ± 8 670 ± 67 1500 ± 61 
Meclizine, 33.9 ± 2.5' 146 ± 19' 614 ± 42 1420 ± 115 
0.5mg 
Meclizine, 25.6 ± 2.3' 114 ± 9- 463 ± 32 1150 ± 79 
1.5 mg 
• Number of mice in each group at the end of the experiment is shown in Table II. 
b Mean ± SEM. 
, p < 0.01 compared to unirradiated, non-drug-treated control group. 
J p < 0.01 compared to irradiated, drug-treated control group. 
DISCUSSION 
A single exposure of mammalian skin to UVB radiation causes an 
increase in several inflammatory mediators including histamine, 
prostaglandin E2 , 12-HETE, interleukin 1, and tumor necrosis fac-
tor-a [17 - 20]. It has been proposed that chronic inflammation is 
involved in the skin changes produced by exposure to UVB radia-
tion over many years, a process called photoaging. This hypothesis 
is supported by the increase in inflammatory cells in the dermis of 
photoaged human skin and chronically irradiated hairless mouse 
skin [1,2,4] . The first goal of this study was to determine whether 
experimental photoaging, as measured by changes in selected der-
mal macromolecules and cells, could be inhibited by systemic ad-
ministration of anti-inflammatory agents . The agents were chosen 
for their abilities to inhibit the formation or action of different 
inflammatory mediators. Thus, a second question asked was 
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whether anyone or all of the agents would selectively inhibit 
chronic UVB-induced dermal changes, thereby indicating that cer-
tain mediators were involved in specific dermal changes. 
Anti-inflammatory agents that have been shown to inhibit 
aspects of acute UV-induced cutaneous inflammation include the 
cyclooxygenase inhibitor, indomethacin, and HI histamine recep-
tor antagonists [21,22]. Several agents tested in preliminary experi-
ments were either ineffective against UVB-induced inflammation 
or were too toxic to be used in chronic studies. The three agents 
chosen for further study, indomethacin, meclizine, and BW755C, 
inhibited signs of acute UVB-induced inflammation, namely, in-
creased vascular permeability, neutrophil accumulation, and in-
creased skin-fold thickness (all measured at 24 h post-irradiation). 
Our results indicate that indomethacin decreased all three responses 
of hairless mouse skin to a single UVB exposure. Meclizine, an HI 
histamine receptor antagonist, inhibited the UVB-induced increase 
in vascular permeability and accumulation of neutrophils. 
BW7.55C, a combined cyclooxygenase and lipoxygenase inhibitor, 
effectively reduced the UVB-induced increase in vascular perme-
ability. 
These results on acute UVB-induced skin injury can be inter-
preted, at least partially, by considering the primary pharmacologic 
effects o~ these ag~nts. For example, the reduction by indomethacin 
m UVB-mduced mcrease of vascular permeability may be attributed 
to reduced formation of PGE2 , which potentiates the increase in 
vascular pe~meability prod~ced by histamine and bradykinin [23]. 
:rhe reductl~m of the UVB-l11duced a~cumulation of neutrophils by 
l11domethacm I?ay also result fr.om Its effect on vasopermeability 
because formation of chemotactIc leukotrienes is not inhibited by 
indomethacin. The inhibition of UVB-induced vasopermeability 
by meclizine is attributed to its activity as an HI-histamine receptor 
antagonist because binding of histamine via HI receptors results in 
increased vasopermeabiliry in murine skin [24). The reduction of 
neutrophil accumulation by meclizine may also be related to its 
abiliry to inhibit the UVB-induced increase in vascular permeabil-
ity. The ability ofBW755C to decrease the UVB-induced increase 
in vascular permeabiliry may be attributed to either its inhibition of 
lipoxygenase or cyclooxygenase activities although it apparently 
was not present at high enough concentration or for a long enough 
period to decrease effectively the production of chemotactic leuko-
trienes. 
Chronic UVB exposure of hairless mouse skin produced increases 
in the amounts per area of all three of the dermal macromolecules 
measured; the relative magnitude of the change was GAGs> 
elastin> collagen. The measurements are made after periods of 
UVB exposure and represent the net change in macromolecular 
content compared to age-matched control animals. The chronic 
Table VI. Effects of Indomethacin, Meclizine, and BW755C on Chronic UVB-Induced 
Changes in Hydroxyproline in Hairless Mouse Skina 
Hydroxyproline, mg/ern2 Hydroxyproline, mg/g 
Group NoUVB 
Experiment 1 
0.73 ± 0.03b None 
Indomethacin, 0.05 mg 0.62 ± 0.04 
Experiment 2 
None 0.93 ± 0.10 
Meclizine, 0.25 mg 1.15 ± 0.12 
BW755C, 37.5 mg/kg 0.76 ± 0.11 ' 
Experiment 3 
None 0.63 ± 0.02 
Indomethacin, 0.10 mg 0.49 ± 0.02-
Experiment 4 
None 0.60 ± 0.02 
Placebo pellet 0.66 ± 0.04 
Meclizine, 0.5 mg 0.61 ± 0.04 
Meclizine, 1.5 mg 0.57 ± 0.02 
• Number of mice in each group at the end of the experiments is shown in Table II. 
'Mean±SEM. 
, p < 0.05 compared to unirradiated, non-drug-treated group. 
UVB NoUVB UVB 
0.84 ± 0.06 13.7 ± 1.5 12.5 ± 0.8 
0.87 ± 0.08 16.0 ± 2.4 15.2 ± 2.0 
1.43 ± 0.25 19 .6 ± 2.6 19.9 ± 3.8 
1.48 ± 0.21 24.1 ± 2.9 18.8 ± 2.2 
0.95 ± 0.07' 15.0 ± 0.7 13.7 ± 1.1 
0.72 ± 0.03 14.9 ± 0.8 9.2 ± 0.7 
0.65 ± 0.03' 15.3 ± 1.2 9.0 ± 1.1 
0.91 ± 0.06 19.7 ± 0.9 11.1 ± 0.6 
0.86 ± 0.05 16.5 ± 1.0 11.0 ± 0.6 
0.73 ± 0.021 18.0 ± 0.8 10.4 ± 0.9 
0.66 ± 0.021 14.7 ± 0.6 7.5 ± 0.5 
J P < 0.01 compared to unirradiated, non - drug-treated group . 
, p < 0.025 compared to irradiated, non-drug-treated group. 
f p < 0.005 compared to irradiated, non-drug-treated group. 
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Table VII. Summary of the Effects of Anti-Inflammatory 
Agents on Chronic UVB-Induced Alterations 
In Hairless Mouse Skin 
Parameter Indomethacin Meclizine BW755C 
Dermal Thickness +, 
Mast cells 
Neutrophils NDb 
Elastin + 
Glycosaminoglycans 
Collagen + + 
• A plus sign indicates that the agent inhibited the UVB-induced increase in that 
parameter. 
I NO, not determined. 
UVB-induced dermal macromolecular changes found in this study 
are simi lar to those reported by others in hairless mouse skin. The 
increase in GAG content is always greatest. An increase in coll agen 
is not always detected and may vary with the extent of the chronic 
UVB damage [1] . Further studies are required to determine whether 
the increases in dermal macromolecules are accompanied by bio-
chemical alterations. 
Several mechanisms could lead to these changes in net macromo-
lecular accumulation including activation of macromolecular syn-
thetic pathways in fibroblasts or inhibition of rates of macromolecu-
lar degradation. The degree of activation of synthesis or inhibition 
of degradation must vary between macromolecules because much 
larger increases are found for GAGs and elastin compared to colla-
gen. An alternative explanation for the UVB-induced increases in 
macromolecule accumulation assumes that fibroblasts in photoaged 
skin increase in number but maintain their normal rates of macromo-
lecular synthesis. The number of dermal fibroblasts increases in 
murine photoaged skin [2]; however, this hypothesis is not consist-
ent with the differing magnitudes by w hich the three macromole-
cu les are increased in UVB-exposed skin. 
Previous work has shown that photoaged ski n contains activated 
fibroblasts [1,4]. Thus, increased synthesis may contribute to the 
increased net accumulation of dermal macromolecules . Although 
decreased rates of degradation may also contribute to increased ac-
cumulation, one study of chronically UVB-exposed hairless mouse 
skin did not demonstrate decreases in activity of proteolytic and 
elastolytic enzymes [8]. Dermal fibroblasts may be directly stimu-
lated by UVB to increase synthesis of macromolecules [25] or indi-
rectly stimulated by mediators elicited from other cells by UVB 
exposures. For example, synthesis of collagen and GAGs by dermal 
fibroblasts in vitro is stimulated by interleukin 10' and p, and tumor 
necrosis factor 0' and p [26]. However, certain cytokines induced by 
UV radiation also stimulate increased fibroblast collagenase activity . 
All three anti- infl ammatory agents inhibited the increase in der-
mal macromolecules induced by chronic UVB exposure indicating, 
in answer to our first question, that inflammatory mediators are 
involved in chronic UVB-induced macromolecular alterations and 
that systemic anti-inflammatory agents can effectively reduce this 
effect. Interestingly, not all agents affected the dermal content of 
each macromolecule in the same ways as shown in Table VII. Indo-
methacin altered the elastin accumul ation, meclizine and BW755C 
inhibited collagen accumulation , but none of the agents altered-the 
GAG increase. Similar but not identical resul ts were obtained in a 
study of the effects of topically applied anti-infl ammatory agents on 
chronic UVB-induced skin changes evaluated histologically [11] . In 
that study, the cyclooxygenase inhibitors, naproxen and ibuprofen, 
inhibited the increase in elastin, similar to our result with indo-
methacin. Only one of the topical cyclooxygenase inhibitors pro-
tected against the increase in GAGs indicating that, similar to our 
result, the GAG increased accumulation is not as sensitive to inhibi-
tion. In contrast, the topical cyclooxygenase inhibitors also inhib-
ited the collagen changes w hereas, in our study, BW755C was 
effective but indomethacin was not. The differences between the 
twO studies may have resulted from the differences in the types of 
measurements; our study measured net changes in amount of macro-
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molecules w hereas the study of Bissett et al [11] measured h istologic 
changes. A further contrast between the resul ts of the two studies is 
that the topical agents suppressed the chronic UVB-induced in-
crease in dermal cellul arity whereas the systemic agents did not alter 
mast cell increases but did decrease UVB-induced neutrophil in-
creases . 
Thus, in answer to our second question, different specific media-
tors appear to be important for the several endpoints measured. For 
example, the inhibition of the elas tin increase by indomethacin may 
be due to blocking of prostaglandin effects on fibroblast or on endo-
thelial cells . In addition, the mediators may be inducing synthesis or 
inhibiting degradation of the macromolecules as noted above. Pros-
taglandins but not histamine appear to be important for chronic 
UVB-enhanced accumulation of elastin, whereas histamine but not 
prostaglandins is important for accumulation of collagen. The ob-
servation that BW755C but not indomethacin decreased the accu-
mulation of collagen indicates that leukotrienes, rather than prosta-
glandins, may be important. 
In summary, it appears that different inflammatory mediators are 
involved in the increased accumulation of elastin, GAGs, and colla-
gen in photoaged skin. Further studies are required to describe the 
detailed interactions and mechanisms involved. 
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